Related Experiment Videos
Gaucher patients with oculomotor abnormalities do not have a unique genotype
E Sidransky1, S Tsuji, B K Stubblefield
1Section on Molecular Neurogenetics, National Institute of Mental Health, ADAMHA, Bethesda, MD 20892.
Clinical Genetics
|January 1, 1992
Summary
Gaucher disease in children can cause slowed eye movements (saccades) and earlier, more severe symptoms. Genotype-phenotype correlations for this specific oculomotor issue remain unclear, urging caution in predicting disease course.
Area of Science:
- Neurology
- Genetics
- Ophthalmology
Background:
- Gaucher disease is a lysosomal storage disorder.
- Oculomotor abnormalities, specifically slowed horizontal saccades, are observed in some Gaucher disease patients.
- The relationship between specific genotypes and this clinical presentation is not well-defined.
Purpose of the Study:
- To describe the clinical phenotype of slowed horizontal saccades in non-Ashkenazic American children with Gaucher disease.
- To investigate potential genotype-phenotype correlations for this specific oculomotor abnormality.
- To highlight the implications for clinical management and prediction of disease progression.
Main Methods:
- Descriptive case series of sixteen non-Ashkenazic American children with Gaucher disease.
- Clinical assessment including neuro-ophthalmologic examinations and electroencephalography (EEG).
- Analysis of patient genotypes, focusing on common Gaucher disease mutations.
Main Results:
- All sixteen children presented with slowed horizontal saccades.
- No unique genotype was consistently associated with this oculomotor phenotype; at least five different genotypes were identified among patients with common mutations.
- Patients often exhibited diffusely slowed EEG background but otherwise normal neurological exams.
- These children experienced earlier and more severe systemic manifestations and mortality.
Conclusions:
- Slowed horizontal saccades represent a specific clinical phenotype in Gaucher disease that is not easily predicted by current genotype analysis.
- Careful sequential neuro-ophthalmologic evaluations are crucial for managing Gaucher disease patients.
- Caution is advised when attempting to predict Gaucher disease progression based solely on DNA mutational analysis.